Matches in SemOpenAlex for { <https://semopenalex.org/work/W2019401661> ?p ?o ?g. }
Showing items 1 to 65 of
65
with 100 items per page.
- W2019401661 endingPage "377" @default.
- W2019401661 startingPage "376" @default.
- W2019401661 abstract "1.Improve the ability to offer safe and effective opioid therapy to patients with serious illness by augmenting conventional guidelines with new information about side effect treatment, management of risks associated with drug abuse, and targeted treatment of breakthrough pain.2.Improve the ability to use adjuvant analgesics to manage bone pain, visceral pain, and neuropathic pain syndromes.3.Use NSAIDs more effectively based on an improved understanding of potential risks and benefits. Given the prevalence of pain in the medically ill, specialists in palliative medicine need a strong skill set in pain management. Pharmacotherapy is the mainstay approach and clinical guidelines for the use of three categories of drugs opioids, nonopioids, and so-called adjuvant analgesics are evolving with new research and experience. Opioid guidelines now confirm that morphine is not the drug of choice but one among many, and differences in risk profiles, particularly as this pertains to methadone, influence drug selection. The importance of breakthrough pain is now clear and treatment decisions have been complicated by the appearance of multiple fentanyl preparations, which have the benefit of more rapid onset but uncertain cost-utility relative to conventional drugs. Opioid side effect management is becoming more sophisticated, particularly with the recognition of side effects such as hypogonadism and sleep-disorder breathing, which may not be perceived by clinicians as being opioid-related. The management of risks associated with the abuse potential of opioid drugs is now viewed as a key responsibility, given the increase of prescription drug abuse in the United States. All of these advances in the safe and effective use of opioids are mirrored in changes that have occurred in the use of other analgesic categories. Slow progress toward mechanism-based treatment has highlighted the non-opioid options for pains of varied mechanisms, such as bone pain, visceral pain and neuropathic pain. Drug combination therapy may offer the optimal balance between analgesia and side effects. This session offers an update on the pharmacotherapy of pain in those with serious illness." @default.
- W2019401661 created "2016-06-24" @default.
- W2019401661 creator A5017540677 @default.
- W2019401661 creator A5090628353 @default.
- W2019401661 date "2014-02-01" @default.
- W2019401661 modified "2023-10-12" @default.
- W2019401661 title "Pharmacotherapy of Pain in Populations with Serious Illness: Best Practices and Emerging Issues (P9)" @default.
- W2019401661 doi "https://doi.org/10.1016/j.jpainsymman.2013.12.011" @default.
- W2019401661 hasPublicationYear "2014" @default.
- W2019401661 type Work @default.
- W2019401661 sameAs 2019401661 @default.
- W2019401661 citedByCount "0" @default.
- W2019401661 crossrefType "journal-article" @default.
- W2019401661 hasAuthorship W2019401661A5017540677 @default.
- W2019401661 hasAuthorship W2019401661A5090628353 @default.
- W2019401661 hasBestOaLocation W20194016611 @default.
- W2019401661 hasConcept C118552586 @default.
- W2019401661 hasConcept C126322002 @default.
- W2019401661 hasConcept C170493617 @default.
- W2019401661 hasConcept C177713679 @default.
- W2019401661 hasConcept C2426938 @default.
- W2019401661 hasConcept C2777107010 @default.
- W2019401661 hasConcept C2778767360 @default.
- W2019401661 hasConcept C2779418921 @default.
- W2019401661 hasConcept C2781063702 @default.
- W2019401661 hasConcept C40010229 @default.
- W2019401661 hasConcept C42219234 @default.
- W2019401661 hasConcept C500440147 @default.
- W2019401661 hasConcept C71924100 @default.
- W2019401661 hasConcept C98274493 @default.
- W2019401661 hasConceptScore W2019401661C118552586 @default.
- W2019401661 hasConceptScore W2019401661C126322002 @default.
- W2019401661 hasConceptScore W2019401661C170493617 @default.
- W2019401661 hasConceptScore W2019401661C177713679 @default.
- W2019401661 hasConceptScore W2019401661C2426938 @default.
- W2019401661 hasConceptScore W2019401661C2777107010 @default.
- W2019401661 hasConceptScore W2019401661C2778767360 @default.
- W2019401661 hasConceptScore W2019401661C2779418921 @default.
- W2019401661 hasConceptScore W2019401661C2781063702 @default.
- W2019401661 hasConceptScore W2019401661C40010229 @default.
- W2019401661 hasConceptScore W2019401661C42219234 @default.
- W2019401661 hasConceptScore W2019401661C500440147 @default.
- W2019401661 hasConceptScore W2019401661C71924100 @default.
- W2019401661 hasConceptScore W2019401661C98274493 @default.
- W2019401661 hasIssue "2" @default.
- W2019401661 hasLocation W20194016611 @default.
- W2019401661 hasOpenAccess W2019401661 @default.
- W2019401661 hasPrimaryLocation W20194016611 @default.
- W2019401661 hasRelatedWork W1965764480 @default.
- W2019401661 hasRelatedWork W1974538875 @default.
- W2019401661 hasRelatedWork W1980316389 @default.
- W2019401661 hasRelatedWork W1986909190 @default.
- W2019401661 hasRelatedWork W2082812888 @default.
- W2019401661 hasRelatedWork W2102808934 @default.
- W2019401661 hasRelatedWork W2599590541 @default.
- W2019401661 hasRelatedWork W2777612558 @default.
- W2019401661 hasRelatedWork W3189436618 @default.
- W2019401661 hasRelatedWork W4285677097 @default.
- W2019401661 hasVolume "47" @default.
- W2019401661 isParatext "false" @default.
- W2019401661 isRetracted "false" @default.
- W2019401661 magId "2019401661" @default.
- W2019401661 workType "article" @default.